Partner Fund Management »

Ascendis Pharma A/s shares owned by Partner Fund Management

Quarter-by-quarter ownership of Ascendis Pharma A/s shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Ascendis Pharma A/s

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A/s held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A/s by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.9M 6.0M 1.16

More positions owned by Partner Fund Management

Eli Lilly & Co. (LLY)
Cytokinetics Com New (CYTK)
Merck & Co (MRK)
Abbvie (ABBV)
Edwards Lifesciences (EW)
Hca Holdings Call Option (HCA)
Vertex Pharmaceuticals Incorporated (VRTX)
Tenet Healthcare Corp Com New (THC)
McKesson Corporation (MCK)
Ishares Tr 4 20 Yr Tr Bd Etf Put Option (TLT)
Centene Corporation (CNC)
Intuitive Surgical Com New (ISRG)
Humana (HUM)
Becton, Dickinson and (BDX)
Legend Biotech Corp Sponsored Ads (LEGN)

View all positions for Partner Fund Management

Top funds holding Ascendis Pharma A/s

Wolverine Asset Management
Franklin Resources
Readystate Asset Management
Aviva
Citadel Advisors
Point72 Asset Management
Davidson Kempner Capital Management
Zazove Associates
State Street Corporation
Polar Capital Holdings
Aequim Alternative Investments
Calamos Advisors
SSI Investment Management
Partner Fund Management
Capstone Investment Advisors

View all funds holding Ascendis Pharma A/s